amiodarone has been researched along with Edema, Fetal in 15 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone." | 7.83 | Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. ( Hsieh, CT; Lin, PH; Tsai, HD; Wu, HH, 2016) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 7.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| "We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone." | 3.83 | Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. ( Hsieh, CT; Lin, PH; Tsai, HD; Wu, HH, 2016) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 3.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| " After failure of initial transplacental treatment, the injection of amiodarone into the umbilical vein combined with evacuation of ascites achieved conversion to sinus rhythm and restored cardiac function thus allowing pregnancy to go to term." | 3.70 | Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. ( Guyon, F; Horovitz, J; Jimenez, M; Mangione, R; Saura, R; Vergnaud, A, 1999) |
| "We report a case of nonimmune hydrops fetalis detected at 32 weeks of gestation." | 2.43 | Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature. ( Kapoor, A; Manisha, M; Pradhan, M; Singh, R, 2006) |
| "Amiodarone was injected slowly into foetal peritoneal cavity under ultrasound guidance." | 1.42 | Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone. ( Coleman, M; Gnanapragasam, J; Howe, D; Kang, SL; Roman, K, 2015) |
| "Amiodarone is the treatment of choice for direct foetal therapy for SVT, and can be administered safely via the umbilical vein." | 1.35 | [Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein]. ( Blom, NA; Klumper, FJ; Oepkes, D; Rijlaarsdam, ME; Roest, AA; Vandenbussche, FP, 2008) |
| "Most arrhythmias associated with fetal hydrops can be controlled with transplacental treatment, but the mortality in this group is 27%." | 1.30 | Fetal tachycardias: management and outcome of 127 consecutive cases. ( Sharland, GK; Simpson, JM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, SL | 1 |
| Howe, D | 1 |
| Coleman, M | 1 |
| Roman, K | 1 |
| Gnanapragasam, J | 1 |
| Capone, CA | 1 |
| Gebb, J | 1 |
| Dar, P | 1 |
| Shenoy, RU | 1 |
| Lin, PH | 1 |
| Wu, HH | 1 |
| Tsai, HD | 1 |
| Hsieh, CT | 1 |
| Jouannic, JM | 2 |
| Delahaye, S | 2 |
| Fermont, L | 2 |
| Le Bidois, J | 2 |
| Villain, E | 2 |
| Dumez, Y | 2 |
| Dommergues, M | 2 |
| Doherty, G | 1 |
| Bali, S | 1 |
| Casey, F | 1 |
| Strasburger, JF | 1 |
| Cuneo, BF | 1 |
| Michon, MM | 1 |
| Gotteiner, NL | 1 |
| Deal, BJ | 1 |
| McGregor, SN | 1 |
| Oudijk, MA | 1 |
| Meijboom, EJ | 1 |
| Feinkind, L | 1 |
| Hussey, M | 1 |
| Parilla, BV | 1 |
| Pradhan, M | 1 |
| Manisha, M | 1 |
| Singh, R | 1 |
| Kapoor, A | 1 |
| Roest, AA | 1 |
| Vandenbussche, FP | 1 |
| Klumper, FJ | 1 |
| Oepkes, D | 1 |
| Rijlaarsdam, ME | 1 |
| Blom, NA | 1 |
| Amiel, C | 1 |
| Chau, C | 1 |
| Millet, V | 1 |
| Agher, JP | 1 |
| Gamerre, M | 1 |
| Simpson, JM | 1 |
| Sharland, GK | 1 |
| Mangione, R | 1 |
| Guyon, F | 1 |
| Vergnaud, A | 1 |
| Jimenez, M | 1 |
| Saura, R | 1 |
| Horovitz, J | 1 |
| Schleich, JM | 1 |
| Bernard Du Haut Cilly, F | 1 |
| Laurent, MC | 1 |
| Almange, C | 1 |
| Hijazi, ZM | 1 |
| Rosenfeld, LE | 1 |
| Copel, JA | 1 |
| Kleinman, CS | 1 |
| Gembruch, U | 1 |
| Manz, M | 1 |
| Bald, R | 1 |
| Rüddel, H | 1 |
| Redel, DA | 1 |
| Schlebusch, H | 1 |
| Nitsch, J | 1 |
| Hansmann, M | 1 |
1 review available for amiodarone and Edema, Fetal
| Article | Year |
|---|---|
Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Echocardiography, Dop | 2006 |
14 other studies available for amiodarone and Edema, Fetal
| Article | Year |
|---|---|
Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans | 2015 |
Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Hypothyr | 2014 |
Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops.
Topics: Adult; Amiodarone; Amnion; Anti-Arrhythmia Agents; Atrial Flutter; Female; Humans; Hydrops Fetalis; | 2016 |
Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Flecainide; Hydrops Fetalis; | 2003 |
Fetal hydrops due to supraventricular tachycardia--successful outcome in a difficult case.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hydrops Fetalis; Pre | 2003 |
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Echocardiography; F | 2003 |
Amiodarone therapy for drug-refractory fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Electrocardiography; Female; Fetal Dise | 2004 |
[Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Pregnanc | 2008 |
[Fetal supraventricular tachycardia. Management].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Digoxin; Drug Therapy, Combination; Female; Fetal Di | 1993 |
Fetal tachycardias: management and outcome of 127 consecutive cases.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Digoxin; Female; Fetal Distr | 1998 |
Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Heart Rate, Fetal; Human | 1999 |
Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow-up.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Gestational Age; Heart Rate, Feta | 2000 |
Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate.
Topics: Adult; Amiodarone; Atrial Flutter; Electrocardiography; Female; Humans; Hydrops Fetalis; Hypothyroid | 1992 |
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hydrops Fetalis; Injections, Intravenous | 1989 |